Jonathan Wolleben
Stock Analyst at JMP Securities
(1.49)
# 1433
Out of 5,328 analysts
204
Total ratings
43.43%
Success rate
10.11%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuti... | Reiterates: Market Outperform | 443 443 | 326.72 | 35.59% | 12 | Apr 24, 2025 | |
MBX MBX Biosciences | Initiates Coverage On: Market Outperform | 38 | 11.26 | 237.48% | 1 | Apr 10, 2025 | |
ALT Altimmune | Reiterates: Market Outperform | 25 25 | 5.2 | 380.77% | 12 | Apr 2, 2025 | |
CLSD Clearside Biomedical | Reiterates: Market Outperform | 5 5 | 0.85 | 488.24% | 10 | Mar 28, 2025 | |
KALV KalVista Pharma | Reiterates: Market Outperform | 19 19 | 13.62 | 39.5% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 21 19 | 6.07 | 213.01% | 7 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 15 | n/a | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 61 61 | 45.16 | 35.08% | 11 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 22 19 | 8.55 | 122.22% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 10 10 | 8.7 | 14.94% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 55 55 | 17.75 | 209.86% | 11 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 8.72 | 106.42% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 26 26 | 5.15 | 404.85% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 91 87 | 27.31 | 218.56% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 92 91 | 33.6 | 170.83% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 74 74 | 43.47 | 70.23% | 9 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 75 75 | 63.8 | 17.55% | 2 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 9 9 | 3.25 | 176.92% | 8 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 55 50 | 36.84 | 35.72% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 90 90 | 76.64 | 17.43% | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 1.72 | 365.12% | 6 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 3 3 | 0.08 | 3650% | 7 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Accumulate | 420 485 | 601.83 | -19.41% | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 3 3 | 0.33 | 809.09% | 6 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 48 32 | 3.94 | 712.18% | 8 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 25 25 | 2.85 | 777.19% | 11 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 0.31 | 2480.65% | 11 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 24 | 30.05 | -20.13% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | May 25, 2021 |